Publications

Publications keep interested parties informed about the latest scientific, clinical, trial-based, and peer-reviewed documentation about our products and pipeline. Find the latest below:

sort by:

FUTURE CARDIOLOGY

2023; 19(8): 385-396.

Reduced heart failure-related healthcare costs with Furoscix versus in-hospital intravenous diuresis in heart failure patients: the FREEDOM-HF study.

view publication

DIABETES THERAPY

2023; 14(3): 611-617

Time–Action Profile of Technosphere Insulin in Children with Type 1 Diabetes

view publication

STRUCTURAL HEART

2022; Aug 7; 6(4): 100076.

From Oral to Subcutaneous Furosemide: The Road to Novel Opportunities to Manage Congestion.

view publication

Annals of Diabetes, Metabolic Disorders & Control

2022; 3(1): 120

Evaluation of a Weekly Physician-Driven Bolus Titration Algorithm in Patients with Type 2 Diabetes Prescribed V-Go® Wearable Insulin Delivery Device for Basal-Bolus Therapy

view publication

Endocrine Practice

2021; 27(5): 449-454

Ultra Rapid-Acting Inhaled Insulin Improves Glucose Control in Patients With Type 2 Diabetes Mellitus

view publication

Pharmacy (Basel).

2020; 8(4): 215

Clinical Evaluation of Basal-Bolus Therapy Delivered by the V-Go ® Wearable Insulin Delivery Device in Patients with Type 2 Diabetes: A Retrospective Analysis

view publication

Drugs Real World Outcomes

2020; 7: 31-40

Effectiveness of V-Go® for Patients with Type 2 Diabetes in a Real-World Setting: A Prospective Observational Study

view publication

Clin. Drug Investigation.

2020; 40: 973–983

Comprehensive Pulmonary Safety Review of Inhaled Technosphere® Insulin in Patients with Diabetes Mellitus.

view publication

Diabet. Med.

2020; 37: 752–759

Hypoglycaemia is reduced with use of inhaled Technosphere® Insulin relative to insulin aspart in type 1 diabetes mellitus.

view publication

Med Devices (Auckl).

2020; 13: 283-91

Multicenter Real-World Assessment of the Effectiveness of V-Go Wearable Insulin Delivery Device in Adult Patients with Type 2 Diabetes (ENABLE Study): A Retrospective Analysis

view publication

J Health Econ Outcomes Res.

2019; 6(2): 70-83

A Pragmatic Clinical Trial to Compare the Real-World Effectiveness of V-Go versus Standard Delivery of Insulin in Patients with Advanced Type 2 Diabetes

view publication

J Manag Care Spec Pharm.

2019; 25(10): 1111-23

Effect of V-Go Versus Multiple Daily Injections on Glycemic Control, Insulin Use, and Diabetes Medication Costs Among Individuals with Type 2 Diabetes Mellitus

view publication
sort by:
<